Decision Impact Trial of KidneyIntelX

This trial is evaluating whether a kidney risk score called KidneyIntelX — a blood test that uses biomarkers to predict how fast kidney disease will progress — actually changes how doctors manage patients with Type 2 diabetes and early-stage diabetic kidney disease (DKD). Researchers want to know if having this test result leads to better or more aggressive care. **You may be eligible if...** - You are 23 or older - You have Type 2 diabetes - You have early-to-moderate diabetic kidney disease (eGFR 30–60, or eGFR over 60 with significant protein in your urine) - Relevant blood and urine tests are available or can be performed **You may NOT be eligible if...** - You do not have Type 2 diabetes - Your kidney disease is more advanced (eGFR below 30) - You do not have evidence of diabetic kidney disease Talk to your doctor to see if this trial is right for you.